The Week in Review: Making Deals

Sanofi-Aventis will acquire BMP Sunstone for $520 million, gaining two China consumer healthcare brands and an extensive distribution network; aTyr Pharma completed a $23 million Series C funding round; Sihuan Pharma jumped 25% to HK$5.77 in the first day of post-IPO trading; China’s 12th Five-Year Plan, with huge implications for life sciences, will be published soon; Lilly (NYSE: LLY) will close its Singapore Center for Drug Discovery and disclose its plans for China R&D within a month; Zhejiang Jingxin Pharma has in-licensed the China rights to an insomnia drug candidate; Aoxing Pharma reported its narcotic drug API operation passed an SFDA inspection; China Sky One asked the SFDA to approve 15 new TCM products; and Sinovac Biotech lowered its 2010 financial guidance by 33%. More details…. Stock Symbols: (NYSE: SNY) (NSDQ: BJGP) (HKEX: 0460) (NYSE Amex: AXN) (NSDQ: CSKI) (NSDQ: SVA)